Developments with investigating descriptors for antimicrobial AApeptides and their derivatives
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 23, 2018 Category: Drugs & Pharmacology Authors: Olapeju Bolarinwa Jianfeng Cai Source Type: research

Strategies for improving the specificity of siRNAs for enhanced therapeutic potential
Volume 13, Issue 8, August 2018, Page 709-725 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 14, 2018 Category: Drugs & Pharmacology Authors: Aditya Kiran Gatta Raghu Chandrashekhar Hariharapura Nayanabhirama Udupa Meka Sreenivasa Reddy Venkata Rao Josyula Source Type: research

Strategies for improving the specificity of siRNAs for enhanced therapeutic potential
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 14, 2018 Category: Drugs & Pharmacology Authors: Aditya Kiran Gatta Raghu Chandrashekhar Hariharapura Nayanabhirama Udupa Meka Sreenivasa Reddy Venkata Rao Josyula Source Type: research

Introduction to biological complexity as a missing link in drug discovery
Volume 13, Issue 8, August 2018, Page 753-763 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 6, 2018 Category: Drugs & Pharmacology Authors: Gary A. Gintant Christopher H. George Source Type: research

Introduction to biological complexity as a missing link in drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 6, 2018 Category: Drugs & Pharmacology Authors: Gary A. Gintant Christopher H. George Source Type: research

Recent advances in models for screening potential osteoporosis drugs
Volume 13, Issue 8, August 2018, Page 741-752 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 5, 2018 Category: Drugs & Pharmacology Authors: D. Merlotti M. Materozzi T. Picchioni S. Bianciardi M. Alessandri R. Nuti L. Gennari Source Type: research

Recent advances in models for screening potential osteoporosis drugs
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 5, 2018 Category: Drugs & Pharmacology Authors: D. Merlotti M. Materozzi T. Picchioni S. Bianciardi M. Alessandri R. Nuti L. Gennari Source Type: research

Proteomic approaches for novel systemic lupus erythematosus (SLE) drug discovery
Volume 13, Issue 8, August 2018, Page 765-777 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 4, 2018 Category: Drugs & Pharmacology Authors: Yaxi Li Tianfu Wu Source Type: research

Proteomic approaches for novel systemic lupus erythematosus (SLE) drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 4, 2018 Category: Drugs & Pharmacology Authors: Yaxi Li Tianfu Wu Source Type: research

Corrigendum
Volume 13, Issue 7, July 2018, Page ix-xi . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - May 28, 2018 Category: Drugs & Pharmacology Source Type: research

Challenges with biomarkers in cancer drug discovery and development
Volume 13, Issue 8, August 2018, Page 685-690 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - May 24, 2018 Category: Drugs & Pharmacology Authors: Ecaterina Ileana Dumbrava Funda Meric-Bernstam Timothy A. Yap Source Type: research

Challenges with biomarkers in cancer drug discovery and development
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - May 24, 2018 Category: Drugs & Pharmacology Authors: Ecaterina Ileana Dumbrava Funda Meric-Bernstam Timothy A. Yap Source Type: research

Recent advances in the discovery and development of TLR ligands as novel therapeutics for chronic HBV and HIV infections
Volume 13, Issue 7, July 2018, Page 661-670 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - May 18, 2018 Category: Drugs & Pharmacology Authors: Keye Du Jia Liu Ruth Broering Xiaoyong Zhang Dongliang Yang Ulf Dittmer Mengji Lu Source Type: research

A systems biology approach to antimalarial drug discovery
Volume 13, Issue 7, July 2018, Page 617-626 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - May 8, 2018 Category: Drugs & Pharmacology Authors: Wilian Augusto Cortopassi Tanos Celmar Costa Franca Antoniana Ursine Krettli Source Type: research

The preclinical discovery and development of cariprazine for the treatment of schizophrenia
Volume 13, Issue 8, August 2018, Page 779-790 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - May 3, 2018 Category: Drugs & Pharmacology Authors: Anna Weso łowska Anna Partyka Magdalena Jastrz ębska-Więsek Marcin Ko łaczkowski Source Type: research

The preclinical discovery and development of cariprazine for the treatment of schizophrenia
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - May 3, 2018 Category: Drugs & Pharmacology Authors: Anna Weso łowska Anna Partyka Magdalena Jastrz ębska-Więsek Marcin Ko łaczkowski Source Type: research

Recent advances in automated protein design and its future challenges
Volume 13, Issue 7, July 2018, Page 587-604 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - April 26, 2018 Category: Drugs & Pharmacology Authors: Dani Setiawan Jeffrey Brender Yang Zhang Source Type: research

Perspectives on the recent developments with green tea polyphenols in drug discovery
Volume 13, Issue 7, July 2018, Page 643-660 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - April 24, 2018 Category: Drugs & Pharmacology Authors: Feng Li Yongli Wang Dapeng Li Yilun Chen Xuguang Qiao Rania Fardous Ashton Lewandowski Jinbao Liu Tak-Hang Chan Q. Ping Dou Source Type: research

What ’s happened over the last five years with high-throughput protein crystallization screening?
Volume 13, Issue 8, August 2018, Page 691-695 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - April 20, 2018 Category: Drugs & Pharmacology Authors: Yibin Lin Source Type: research

What ’s happened over the last five years with high-throughput protein crystallization screening?
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - April 20, 2018 Category: Drugs & Pharmacology Authors: Yibin Lin Source Type: research

Identification of glia phenotype modulators based on select glial function regulatory signaling pathways
Volume 13, Issue 7, July 2018, Page 627-641 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - April 20, 2018 Category: Drugs & Pharmacology Authors: Sun-Hwa Lee Kyoungho Suk Source Type: research

Progress with modeling activity landscapes in drug discovery
Volume 13, Issue 7, July 2018, Page 605-615 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - April 19, 2018 Category: Drugs & Pharmacology Authors: Martin Vogt Source Type: research

Advancing drug discovery via GPU-based deep learning
Volume 13, Issue 7, July 2018, Page 579-582 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - April 18, 2018 Category: Drugs & Pharmacology Authors: Erik Gawehn Jan A. Hiss J. B. Brown Gisbert Schneider Source Type: research

The consequences of ‘Brexit’ for drug discovery and development, and the regulatory implications
Volume 13, Issue 7, July 2018, Page 583-585 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - April 16, 2018 Category: Drugs & Pharmacology Authors: Bernard T. Golding Michael J. Waring Source Type: research

Discovery and development of varenicline for smoking cessation
Volume 13, Issue 7, July 2018, Page 671-683 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - March 28, 2018 Category: Drugs & Pharmacology Authors: Chloe J. Jordan Zheng-Xiong Xi Source Type: research

Lost in translation? A critical look at the role that animal models of obsessive compulsive disorder play in current drug discovery strategies
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - December 24, 2017 Category: Drugs & Pharmacology Authors: Kurt Leroy Hoffman Hugo Cano-Ram írez Source Type: research

Docking studies for melatonin receptors
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - December 22, 2017 Category: Drugs & Pharmacology Authors: Hanan Awad Alkozi Jos é Maria Sánchez Montero Antonio Luis Doadrio Jesus Pintor Source Type: research

Phenotypic screening approaches for Chagas disease drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - December 21, 2017 Category: Drugs & Pharmacology Authors: Eric Chatelain Jean-Robert Ioset Source Type: research

Urinary peptidomics in kidney disease and drug research
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - December 20, 2017 Category: Drugs & Pharmacology Authors: Magdalena Krochmal Joost P Schanstra Harald Mischak Source Type: research

Binding modes of hERG blockers: an unsolved mystery in the drug design arena
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - December 19, 2017 Category: Drugs & Pharmacology Authors: Subha Kalyaanamoorthy Khaled H. Barakat Source Type: research

Successes and failures of uterine leiomyoma drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - December 19, 2017 Category: Drugs & Pharmacology Authors: Mohamed Ali Zunir Tayyeb Chaudhry Ayman Al-Hendy Source Type: research

Challenges with modelling anxiety disorders: a possible hindrance for drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - December 18, 2017 Category: Drugs & Pharmacology Authors: Florian Freudenberg Aet O ’Leary Daniele C. Aguiar David A. Slattery Source Type: research

Improving the efficacy-safety balance of polypharmacology in multi-target drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - December 13, 2017 Category: Drugs & Pharmacology Authors: Balaguru Ravikumar Tero Aittokallio Source Type: research

The use of databases, data mining and immunoinformatics in vaccinology: where are we?
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - December 11, 2017 Category: Drugs & Pharmacology Authors: Nagendra R. Hegde S. Gauthami H. M. Sampath Kumar Jagadeesh Bayry Source Type: research

Non-alcoholic fatty liver disease (NAFLD) models in drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - December 6, 2017 Category: Drugs & Pharmacology Authors: Banumathi K. Cole Ryan E. Feaver Brian R. Wamhoff Ajit Dash Source Type: research

Improving the attrition rate of Lanthipeptide discovery for commercial applications
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - December 2, 2017 Category: Drugs & Pharmacology Authors: Mengxin Geng Leif Smith Source Type: research

Humanized mouse models infected with human Plasmodium species for antimalarial drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 29, 2017 Category: Drugs & Pharmacology Authors: Alicia Moreno-Sabater Jean Louis P érignon Dominique Mazier Catherine Lavazec Valerie Soulard Source Type: research

Novel avenues for drug discovery in diabetic kidney disease
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 17, 2017 Category: Drugs & Pharmacology Authors: Matthew D. Breyer Matthias Kretzler Source Type: research

Recent developments concerning the application of the Mannich reaction for drug design
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 15, 2017 Category: Drugs & Pharmacology Authors: Bernhard Biersack Khursheed Ahmed Subhash Padhye Rainer Schobert Source Type: research

Molecular dynamics simulations and novel drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 15, 2017 Category: Drugs & Pharmacology Authors: Xuewei Liu Danfeng Shi Shuangyan Zhou Hongli Liu Huanxiang Liu Xiaojun Yao Source Type: research

Recent developments concerning the application of the Mannich reaction for drug design
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 15, 2017 Category: Drugs & Pharmacology Authors: Bernhard Biersack Khursheed Ahmed Subhash Padhye Rainer Schobert Source Type: research

Molecular dynamics simulations and novel drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 15, 2017 Category: Drugs & Pharmacology Authors: Xuewei Liu Danfeng Shi Shuangyan Zhou Hongli Liu Huanxiang Liu Xiaojun Yao Source Type: research

Corrigendum
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 9, 2017 Category: Drugs & Pharmacology Source Type: research